Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
18
2024
Cadwalader Climate (March 18, 2024) Cadwalader, Wickersham & Taft LLP
Mar
18
2024
China Announces the Standard for Food Packaging Adhesives Keller and Heckman LLP
Mar
18
2024
Nevada Supreme Court Reverses $48 Million Verdict, Concludes Hospitals Do Not Owe Fiduciary Duty to Patients in the Provision of Medical Services Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
15
2024
Recent Federal Developments for March 2024 Bergeson & Campbell, P.C.
Mar
15
2024
China Announces the Standard for Food-Contact Adhesives Keller and Heckman LLP
Mar
15
2024
USDA FSIS Final Rule for Voluntary “Product of the USA” Claims Keller and Heckman LLP
Mar
14
2024
Clinical Research: FDA Issues Draft Guidance on Informed Consent Foley & Lardner LLP
Mar
14
2024
Optimizing Obviousness: Routine Optimization Can Fill in Prior Art Gaps McDermott Will & Emery
Mar
14
2024
My Healthy Food Product is Ready to Go to Market – What About its Packaging? Foley & Lardner LLP
Mar
14
2024
Draft European Commission Proposal May Significantly Impact Plastic Food-Contact Materials Keller and Heckman LLP
Mar
13
2024
White House OSTP Posts Readout of NNI Symposium Celebrating 20th Anniversary of the 21st Century Nanotechnology R&D Act Bergeson & Campbell, P.C.
Mar
13
2024
Clinical Trials: FDA Issues Finalized Charging Guidance for Investigational Drug Use Foley & Lardner LLP
Mar
13
2024
Oregon Reinstates $20 Million Subrogation Case Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
13
2024
Adverse Reports Related to Certain Tejocote Root Dietary Supplements Continue Keller and Heckman LLP
Mar
13
2024
FDA Issues Guidance for Foods Made from Genome-Edited Plants Womble Bond Dickinson (US) LLP
Mar
13
2024
Litigation Minute: Beauty from Within and the Confusing Claims Landscape K&L Gates
Mar
13
2024
This Week in 340B: March 5 – 12, 2024 McDermott Will & Emery
Mar
12
2024
FDA Needs a New Approach to AI/ML-Enabled Medical Devices Mintz
Mar
12
2024
Cancer Drugs: Antibody Drug Conjugates (ADCs) Keep Growing Foley & Lardner LLP
Mar
12
2024
FDA Publishes Stance on Titanium Dioxide in Food Keller and Heckman LLP
Mar
11
2024
NIOSH Highlights 20 Years of Research on Engineering Controls for Nanotechnology Bergeson & Campbell, P.C.
Mar
11
2024
Delta-Nope: Florida Poised to Ban Delta-8 and Delta-10 Products Bradley Arant Boult Cummings LLP
Mar
11
2024
Competition Currents | March 2024 Greenberg Traurig, LLP
Mar
11
2024
Healthcare Preview for the Week of: March 11, 2024 [Podcast] McDermott Will & Emery
Mar
11
2024
USDA Releases Reports on Economic Impact Analysis of the U.S. Biobased Products Industry and on Hemp Research and Innovation Bergeson & Campbell, P.C.
Mar
11
2024
The Return of the New York Junk Food Bill Keller and Heckman LLP
Mar
9
2024
Oregon Prescription Drug Price Transparency Act in Limbo Sheppard, Mullin, Richter & Hampton LLP
Mar
8
2024
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins